Amneal – Recall of ranitidine
January 10, 2020 - Amneal announced a voluntary, consumer-level recall of prescription ranitidine tablets because of the potential presence of N-nitrosodimethylamine (NDMA) levels above the acceptable daily intake levels established by the FDA.
Download PDF
